Combined cytogenetic and array-based comparative genomic hybridization analyses of Wilms tumors: Amplification and overexpression of the multidrug resistance associated protein 1 gene (MRP1) in a metachronous tumor

Cancer Genetics and Cytogenetics

Volumn 141, Issue 2, 2003, Pages 120-127

  Goldstein, Myriam ^a   Rennert, Hanna ^a   Bar Shira, Anat ^a   Burstein, Yoav ^a   Yaron, Yuval ^a   Orr Urtreger, Avi ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

MULTIDRUG RESISTANCE PROTEIN 1;

ARTICLE; CANCER GROWTH; CANCER RECURRENCE; CASE REPORT; CHILD; CHROMOSOME ANALYSIS; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE AMPLIFICATION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; KARYOTYPE; LUNG METASTASIS; MALE; NEPHROBLASTOMA; PRIORITY JOURNAL;

BLOTTING, SOUTHERN; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KIDNEY NEOPLASMS; LOSS OF HETEROZYGOSITY; MALE; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NEOPLASMS, SECOND PRIMARY; NUCLEIC ACID HYBRIDIZATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; WILMS TUMOR;

EID: 0037372017     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(02)00667-2     Document Type: Article

References (31)

1. Huff V. Wilms tumor genetics. Am J Med Genet. 79:1998;260-267.
2. Coppes M.J., Arnold M., Beckwith J.B., Ritchey M.L., D'Angio G.J., Green D.M., Breslow N.E. Factors affecting the risk of contralateral Wilms tumor development. a report from the National Wilms Tumor Study Group Cancer. 85:1999;1616-1625.
3. Beckwith J.B. Nephrogenic rests and the pathogenesis of Wilms tumor. developmental and clinical considerations Am J Med Genet. 79:1998;268-273.
4. Hennigar R.A., O'Shea P.A., Grattan-Smith J.D. Clinicopathologic features of nephrogenic rests and nephroblastomatosis. Adv Anat Pathol. 8:2001;276-289.
5. Lee S.B., Haber D.A. Wilms tumor and the WT1 gene. Exp Cell Res. 264:2001;74-99.
6. Steenman M., Westerveld A., Mannens M. Genetics of Beckwith-Wiedemann syndrome-associated tumors. common genetic pathways Genes Chromosomes Cancer. 28:2000;1-13.
7. Grundy P.E., Telzerow P.E., Breslow N., Moksness J., Huff V., Paterson M.C. Loss of heterozygosity for chromosomes 16q and 1p in Wilms' tumors predicts an adverse outcome. Cancer Res. 54:1994;2331-2333.
8. Peier A.M., Meloni A.M., Erling M.A., Sandberg A.A. Involvement of chromosome 7 in Wilms tumor. Cancer Genet Cytogenet. 79:1995;92-94.
9. Grundy R.G., Pritchard J., Scambler P., Cowell J.K. Loss of heterozygosity on chromosome 16 in sporadic Wilms' tumor. Br J Cancer. 78:1998;1181-1187.
10. Bordow S.B., Norris M.D., Haber P.S., Marshall G.M., Haber M. Prognostic significance of MYCN oncogene expression in childhood neuroblastoma. J Clin Oncol. 16:1998;3286-3294.
11. Betts D.R., Koesters R., Pluss H.J., Niggli F.K. Routine karyotyping in Wilms tumor. Cancer Genet Cytogenet. 96:1997;151-156.
12. Schrock E., du Manoir S., Veldman T., Schoell B., Wienberg J., Ferguson-Smith M.A., Ning Y., Ledbetter D.H., Bar-Am I., Soenksen D., Garini Y., Ried T. Multicolor spectral karyotyping of human chromosomes. Science. 273:1996;494-497.
13. ISCN. An international system for human cytogenetic nomenclature. Mitelman F, editor. Basel: S. Karger, 1995.
14. Southern E.M. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol. 98:1975;503-517.
15. Bieche I., Franc B., Vidaud D., Vidaud M., Lidereau R. Analyses of MYC, ERBB2, and CCND1 genes in benign and malignant thyroid follicular cell tumors by real-time polymerase chain reaction. Thyroid. 11:2001;147-152.
16. Dome J.S., Coppes M.J. Recent advances in Wilms tumor genetics. Curr Opin Pediatr. 14:2002;5-11.
17. Coppes M.J., Pritchard-Jones K. Principles of Wilms' tumor biology. Urol Clin North Am. 27:2000;423-433. viii.
18. Schutte BC, Carpten JD, Forus A, Gregory SG, Horii A, White PS. Report and abstracts of the sixth international workshop on human chromosome 1 mapping 2000. Iowa City, Iowa, USA. 30 September-3 October 2000. Cytogenet Cell Genet 2001;92:23-41.
19. Hing S., Lu Y.J., Summersgill B., King-Underwood L., Nicholson J., Grundy P., Grundy R., Gessler M., Shipley J., Pritchard-Jones K. Gain of lq is associated with adverse outcome in favorable histology Wilms' tumors. Am J Pathol. 158:2001;393-398.
20. Miozzo M., Perotti D., Minoletti F., Mondini P., Pilotti S., Luksch R., Fossati-Bellani F., Pierotti M.A., Sozzi G., Radice P. Mapping of a putative tumor suppressor locus to proximal 7p in Wilms tumors. Genomics. 37:1996;310-315.
21. Coppes M.J., Egeler R.M. Genetics of Wilms' tumor. Semin Urol Oncol. 17:1999;2-10.
22. Ward A. Beck-Wiedemann syndrome and Wilms' tumour. Mol Hum Reprod. 3:1997;157-168.
23. Klamt B., Schulze M., Thate C., Mares J., Goetz P., Kodet R., Scheulen W., Weirich A., Graf N., Gessler M. Allele loss in Wilms tumors of chromosome arms 11q, 16q, and 22q correlate with clinicopathological parameters. Genes Chromosomes Cancer. 22:1998;287-294.
24. Wang-Wuu S., Soukup S., Bove K., Gotwals B., Lampkin B. Chromosome analysis of 31 Wilms' tumors. Cancer Res. 50:1990;2786-2793.
25. Steenman M., Redeker B., de Meulemeester M., Wiesmeijer K., Voute P.A., Westerveld A., Slater R., Mannens M. Comparative genomic hybridization analysis of Wilms tumors. Cytogenet Cell Genet. 77:1997;296-303.
26. Ramachandran C., Melnick S.J. Multidrug resistance in human tumors-molecular diagnosis and clinical significance. Mol Diagn. 4:1999;81-94.
27. Re G.G., Willingham M.C., el Bahtimi R., Brownlee N.A., Hazen-Martin D.J., Garvin A.J. Anaplasia and drug selection-independent overexpression of the multidrug resistance gene, MDR1, in Wilms' tumor. Mod Pathol. 10:1997;129-136.
28. Ramachandran C., Melnick S.J., Escalon E., Jhabvala P., Khatib Z., Alamo A., Smith S. Expression of apoptosis, cell proliferation, and drug resistance genes in pediatric Wilms' tumors. Anticancer Res. 20:2000;3759-3765.
29. Kruh G.D., Gaughan K.T., Godwin A., Chan A. Expression pattern of MRP in human tissues and adult solid tumor cell lines. J Natl Cancer Inst. 87:1995;1256-1258.
30. Efferth T., Thelen P., Schulten H.G., Bode M.E., Granzen B., Beniers A.J., Mertens R., Ringert R.H., Gefeller O., Jakse G., Fuzesi L. Differential expression of the multidrug resistance-related protein MRP1 in the histological compartments of nephroblastomas. Int J Oncol. 19:2001;367-371.
31. Paulino A.C., Thakkar B., Henderson W.G. Metachronous bilateral Wilms' tumor. the importance of time interval to the development of a second tumor Cancer. 82:1998;415-420.